FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18205011000001105: Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62496001000001119 Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62496101000001118 Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Is a Doxazosin 4mg modified-release tablets 28 tablet true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has AMP Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Doxazosin mesilate true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Cardozin XL 4mg tablets (Almus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start